Contraceptive strategies for young women in the 21st century

European Journal of Contraception and Reproductive Health Care

Volumn 4, Issue 4, 1999, Pages 255-263

  Ruusuvaara, L ^a,b   Johansson, E D B ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b POPULATION COUNCIL   (United States)

Author keywords

Contraceptives; Education; Parents; Policy; Young women

Indexed keywords

LEVONORGESTREL;

ABORTION; CONDOM; CONTRACEPTION; EXPERIENCE; FERTILITY; FUTUROLOGY; HUMAN RIGHTS; PATIENT COMPLIANCE; PATTERN RECOGNITION; POLICY; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEXUAL EDUCATION; WELLBEING;

EID: 0033493366     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189909071346     Document Type: Review

References (62)

1. 1. Ketting E, Visser A. Contraception in the Netherlands: the low abortion rate explained. Patient Educ Couns 1994; 3; 161-71
2. 2. Bongaarts J. Demographic consequences of declining fertility. Science 1998; 282; 419-20
3. 3. UNFPA. The State of World Population. New York: United Nations Population Fund, 1999
4. 4. National Center for Health Statistics, Birth final data for 1997. Nat Vital Stat Rep 1999; 47(18): 22
5. 5. Stolberg SG. Birth rate at new low as teen-age pregnancy declines. New York Times (National) 19 April, 1999: A26
6. 6. Saul R. Teen pregnancy rates: progress meets politics. Guttmacher Rep 1999; 1: 6
7. 7. 1999 World Population Data Sheet. Washington, DC: Population Reference Bureau, 1999
8. 8. UNFPA. The Right to Choose: Reproductive Rights and Reproductive Health: Summary of State of World Population 1997. New York: United Nations Population Fund, 1998: 1-28
9. 9. Johansson E. Overview: contraceptive research accomplishments in the 20th century and present use of contraceptives. In Coutinho E, Spinola P, eds. Reproductive Medicine: A Millennium Review, Carnforth, UK: The Parthenon Publishing Group, 1999: 92-9
10. 10. World Health Organization Task Force for Epidemiological Research on Reproductive Health. Effects of Contraceptives on Hemoglobin and Ferritin. Geneva: WHO, 1998; 50: 261-73
11. 11. Andersson K. Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990; 97: 690-4
12. 12. Lahteenmaki P, Haukkamaa M, Poulakka J, et al. Open randomized study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. Br Med J 1998; 36: 1122-6
13. 13. Van Hooff M, Hirasing RA, Kaptein M, Koppenaal C, Voorhorst FJ, Schoemaker J. The use of oral contraception by adolescents for contraception, menstrual cycle problems or acne. Acta Obstet Gynecol Scand 1998; 77: 898-904
14. 14. den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception 1999; 59: 357-62
15. 15. Kristjansdottir J, Johansson EDB, Ruusuvaara L-R. The cost of the menstrual cycle in young Swedish women. Eur J Contracept Reprod Health Care 2000; 5: in press
16. 16. Kite S. Family planning provision: whose needs are being met? Br J Fam Plann 1990; 16: 109-13
17. 17. Rome ES. Contraception in adolescence. In Dramusic V, Ratnam SS, eds. Clinical Approach to Paediatric and Adolescent Gynaecology. Oxford: Oxford University Press, 1998: 264-80
18. 18. Gallup Organization Inc. Attitudes Toward Contraception. Princeton, NJ: Gallup Organization, 1995: 40
19. 19. Jones EE, Forrest JD. Contraceptive failure rates based on the 1988 National Survey of Family Growth. Fam Plann Perspect 1992; 19: 12-19
20. 20. United Nations. Levels and trends in contraceptive use. In United Nations World Contraceptive Use. New York: United Nations, 1996
21. 21. Hatcher RA. Contraceptive Technology. New York: Ardent Media, Inc., 1988
22. 22. Mishell DR Jr. Noncontraceptive health benefits of oral steroidal contraceptives. Am J Obstet Gynecol 1982; 142: 809-16
23. 23. Redmond GP, Olson WH, Lippman JS. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol 1997; 89; 615-22
24. 24. Lucky AW, Henderson TA, Olson WH. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol 1997; 37; 746-54
25. 25. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Endometrial cancer and combined oral contraceptives. Int J Epidemiol 1988; 17: 263-9
26. 26. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl J Med 1987; 316: 650-5
27. 27. Rolfs RT, Galaid El, Zaidi AA. Pelvic inflammatory disease: trends in hospitalizations and office visits, 1979 through 1988. Am J Obstet Gynecol 1992; 166: 983-90
28. 28. Kleerekoper M, Brienza RS, Schultz L, Johnson C. Oral contraceptive use may protect against low bone mass. Arch Intern Med 1991; 151: 1971-6
29. 29. Akerlund M, Rode A, Westergaard J. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 mcg, desogestrel and either 30 mcg or 20 mcg ethinyl estradiol. Br J Obstet Gynaecol 1993; 100: 832-8
30. 30. World Health Organization. WHO Annual Technical Report 1996. Geneva: World Health Organization, 1997: 131-3
31. 31. Trussell J, Koenig J, Charlotte E, Stewart F. Preventing unintended pregnancy: the cost-effectiveness of three methods of emergency contraception. Am J Public Health 1997; 87: 932-7
32. 32. Fraser IS, Tiitinen A, Affandi B, et al. Norplant® consensus statement and background review. Contraception 1998; 57: 1-9
33. 33. Sivin I, Campodonico I, Kiriwat O, et al. The performance of levonorgestrel rod and Norplant® contraceptive implants: a five year randomized study. Hum Reprod 1998; 13: 3371-8
34. 34. Andersson K, Olind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994; 49: 56-72
35. 35. Nilsson CG, Lahteenmaki PL, Luukkainen T. Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing iturauterine device. Fertil Steril 1984; 41: 52-5
36. 36. Barbosa I, Bakos O, Olsson S-E, et al Ovarian function during use of a levonorgestrel-releasing IUD. Contraception 1990; 42: 51-66
37. 37. Task Force on Postovulatory Methods of Fertility Regulation. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998; 352: 428-33
38. 38. Winikoff B, Sivin I, Kurus MA, et al. Safety, efficacy and acceptability of medical abortion in China, Cuba and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 1997; 176: 431-7
39. 39. Spitz I, Bardin W, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338: 1241-7
40. 40. Centers for Disease Control. Nat Vital Stat Rep 1998; 47: 32
41. 41. Centers for Disease Control. Youth Risk Behavior Surveillance Survey. Atlanta: Centers for Disease Cortrol, 1999
42. 42. European Society of Contraception. Teenagers and sex: many risks. Q Newslett 1999; 9: 1-4
43. 43. Tyden T. 'It mil not happen to me.' Sexual behaviour among high school and university students and evaluation of STD-prevention programmes [Thesis]. Uppsala, Sweden: Uppsala University, 1996
44. 44. Tyden R, Norden L, Ruusuvaara L. Swedish adolescents' knowledge of sexually transmitted diseases and their attitudes to the condom. Midwifery 1991; 7: 25-30
45. 45. Klanager B, Tyden T, Ruusuvaara L. Sexual behavior among adolescents in Uppsala, Sweden. J Adolesc Health 1993; 14; 468-74
46. 46. Zoccolillo M, Meyers J, Assiter S. Conduct disorder, substance dependence and adolescent motherhood. Am J Orthopsychiatry 1997; 67: 152-7
47. 47. Seamark CJ, Gray DJ. Like mother, like daughter: a general practice study of maternal influences on teenage pregnancy. Br J Gen Pract 1997; 47: 175-6
48. 48. Marot F. Teenagers and sex: a suitable case for education. Professional Care Mother & Child 1994; March: 46-9
49. 49. Sundberg U, ed. The Statistical Yearbook of Sweden. Stockholm: Statistics Sweden, 1993
50. 50. The Alan Guttmacher Institute. Into a New World: Young Women's Sexual and Reproductive Lives. New York: The Alan Guttmacher Institute, 1998: 11-44
51. 51. Marsiglio W, Mott FL. Impact of sex education on sexual activity and contraceptive use and premarital pregnancy among American teenagers. Fam Plann Perspect 1986; 18: 151-2
52. 52. Jones EF. Teenage pregnancy in developed countries: determinants and policy implications. Fam Plann Perspect 1985; 17: 53-63
53. 53. Andersson-Ellstrom A, Forssman L. Sexually transmitted diseases - knowledge and attitudes among young people. J Adolesc Health 1991; 12: 72-6
54. 54. Mitchell-DiCenso A, Thomas BH, Devlin MC, et ail. Evaluation of an educational program to prevent adolescent pregnancy. Health Educ Behav 1997; 24: 300-12
55. 55. Mellanby AR, Phelps FA, Crichton NJ, Tripp JH. School sex education: an experimental programme with educational and medical benefit. Br Med J 1995; 311: 414-17
56. 56. Alexander E, Hickner J. First coitus for adolescents: understanding why and when. J Am Board Fam Practice 1997; 10: 96-103
57. 57. Westera DA, Bennett LR. Population-focused research: a broad-based survey of teens' attitudes, beliefs and behaviours. Int J Nurs Stud 1994; 31: 521-31
58. 58. Fisher M. Parents' views of adolescent health issues. Pediatrics 1992; 90: 335-41
59. 59. Oakley A, Fullerton D, Holland J, et al. Sexual health education interventions for young people: a methodological review. Br Med J 1995; 310: 158-62
60. 60. Woodcock C, Glickman M, Barker M, Power C. Children, Teenagers and Health. Buckingham: Open University Press, 1993
61. 61. Wight D. Impediments to safer heterosexual sex: a review of research with young people. AIDS Care 1992; 4: 11-21
62. 62. Bilbrey J, Chavkin W. Can we talk? In Choice Notes: A Publication of Physicans for Reproductive Choice and Health 1999: 4: 1-8